Furthermore, our finding could be supported by a study that reveal how miR-181a can enhances drug sensitivity in BC by targeting breast cancer resistance protein (BCRP/ABCG2) (Jiao et al., 2013). The gene discussed is ABCG2; the disease is breast cancer.